13. Both chronic and short-term use of _____________ is associated with an increased risk of myocardial infarction or stroke. A. Acetaminophen. B. Gabapentin. C. NSAIDs. D. Cyclobenzaprine.
19. All of the following are associated with more severe cases of benzodiazepine withdrawal EXCEPT: A. Longer durations of benzodiazepine use before discontinuation. B. Abrupt discontinuation after regular use. C. Use of benzodiazepines with a longer half-life. D. Use of higher benzodiazepine doses. 20. Which of the following benzodiazepines is preferred in alcohol withdrawal patients who do not have severe liver disease?
14. Which of the following is a partial agonist at the mu-opioid receptor?
A. Tramadol. B. Fentanyl. C. Methadone. D. Naloxone.
A. Alprazolam. B. Lorazepam. C. Temazepam. D. Diazepam.
15. It may be difficult to titrate doses up when using ________ because pain can escalate quickly at the end of life.
A. Liquid morphine. B. Fentanyl patches. C. Intravenous hydromorphone. D. Buccal fentanyl lozenges.
16. Which of the following is a symptom used in the diagnosis of substance use disorder? A. Wanting to cut down or stop using a substance and being able to. B. Using a substance for shorter time than intended or in smaller amounts. C. Giving up substance use, particularly when it causes relationship problems. D. Continuing to use substances even when they put the patient in danger. 17. Which of the following treatments for opioid use disorder is a schedule II controlled substance that can only be administered for medically supervised withdrawal at federally designated outpatient treatment programs or inpatient hospital settings? A. Methadone. B. Buprenorphine. C. Naloxone. D. Naltrexone. 18. If a patient were to experience an opioid overdose, all of the following symptoms would be likely related to overdose EXCEPT? A. Slow or shallow breathing. B. Clammy skin. C. Fast heart rate. D. Blue or purple lips.
46
Powered by FlippingBook